- Why global CEOs are still bullish on ChinaMultinational corporations from the U.S., Europe, Japan and Korea continue to pump billions of investment dollars into China despite its slowing economy and the protracted U.S.-China trade war. So says Bloomberg in a report this week noting that foreign direct investment into China rose nearly 3% in the first nine months of 2019 from a […]
- China Has Always Trailed the U.S. in Chipmaking. In the Trade War Era, Will It Finally Catch Up?Conflict with the U.S., it seems, is incentivizing China to innovate.
- The Trade War Cost U.S. Farmers Their China Market. A Deal Might Not Bring It BackChina's agricultural landscape has transformed in recent months—not just because of the trade conflict.
- Tesla Is About to Get New Competition in EuropeA roughly $39,000 sport utility vehicle looks set to become the first Chinese entrant in Europe’s electric-car market.
- China Biotech BeiGene Wins FDA Approval for Rare Blood Cancer DrugThe FDA has approved China-based biotech BeiGene's blood cancer drug. The victory could boost Amgen—and China's drug industry at large.
- In China’s Bumpy World of Electric Cars, One Startup Is Gaining SpeedThis is your Data Sheet for Thursday, November 14, 2019
- From Airline Conferences to Tattoo Conventions, Everything's Being Canceled in Hong KongUnrest has torpedoed events from fireworks displays and theater shows. Organizers have blamed the protests, saying the safety of participants is paramount.
Skip to Content